Learn if You Have a Claim Against Amarin Pharmaceuticals, Inc. (makers of Permax)

Parkinson's Disease Drug Permax Tied to Heart Disorders in Some Patients Kahn Gauthier Swick is investigating possible legal actions against Amarin Pharmaceuticals, Inc., the manufacturer of the prescription drug Permax (pergolide mesylate), to recover for heart damage suffered by some patients taking the drug.
Claimant Information

Are you submitting this information on behalf of yourself?	Yes No
Are you submitting this information on behalf of a family member?	Yes No
If yes, please provide: Name
Age
Relationship
Permax Use

Date you began taking Permax
Date you stopped taking Permax
Medical Information

Please describe the nature and extent of your injuries resulting from your use of Permax. Particularly, did you suffer any heart damage after taking Permax? Does this damage include heart valve damage?
Are you presently covered by health insurance?	Yes No
Have you previously retained an attorney to represent you in this matter?	Yes No

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Medical Malpractice Takes Enormous Toll on American Families

Kahn Gauthier Swick is investigating legal actions on behalf of patients who were harmed by medical malpractice, and their families. Medical malpractice encompasses all negligence by medical care providers that causes harm to the patient.

California Pharmacists File Suit against Medco and Merck for Alleged Anticompetitive Behavior

A company is caught engaging in anticompetitive behavior, either state or federal antitrust law may be used against it. A class action has been filed against Medco Health Solutions, Inc. and Merck & Company on behalf of California pharmacists, who allege that the companies engaged in anticompetitive behavior in violation of state antitrust law.

Chito-Trim, TurboTone, Impulse Female Herbal Blend/ Maximus Male Herbal Blend Marketers Settle Deceptive Advertising Suit for $750,000

The parties have reached a $750,000 settlement in an FTC administrative proceeding filed against dietary supplement marketer VisionTel Communications, LLC, on behalf of all persons who purchased Chito-Trim or TurboTone for weight loss, or Impulse Female Herbal Blend/ Maximus Male Herbal Blend for male and female sexual dysfunction. The action alleged that the marketers made deceptive advertising claims about these products in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information.

U.S. Consumers May Have Paid Too Much For Procardia XL

A class action has been filed against Pfizer, Inc. and Mylan Laboratories, Inc. alleging that the two companies conspired to prevent the marketing of a generic version of the drug Procardia XL, thereby costing consumers money.

Tripos Charged with Hiding Business Reverses

A class action has been filed against Tripos, Inc. (Nasdaq: TRPS) and certain of its officers and directors by stockholders who purchased the company's common stock between January 9 and July 1, 2002.

New Case Filed Against Beverly Enterprises, Details Not Yet Available

A class action lawsuit has been filed in US District Court against Arkansas based Beverly Enterprises, Inc. d/b/a Beverly Healthcare The case involves violations of contract law. No additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available.